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The Ethics of
International Bureaucracies
Abortion and the Human Reproduction Programme
An interview with Australian Senator Brian Harradine
Canberra, Australia, April, 1990

The World Health Organization (WHO) is involved in many laudable
activities, supported by thousands of loyal and active workers, both in the
field and in educational, scientific, health, and medical establishments.
To many of these dedicated workers, it will be a source of much
disappointment and shame, therefore, to learn that WHO has become
involved in activities in which its motto "healthfor all" is being interpreted
in such a way as to discriminate against the health and well-being of
particular unborn children.
In this interview, Senator Harradine seeks to answer matters of serious
concern which have arisen concerning the direction of the Human
Reproduction Programme (HRP) of which WHO is co-sponsor and
executing agency.

The Human Reproduction Programme
THE HUMAN REPRODUCTION PROGRAMME (HRP) was established in 1971-72 by the World Health Organisation to "coordinate, promote,
conduct and evaluate international research in human reproduction."1 Its full
title is "The Special Programme of Research, Development and Research
Training in Human Reproduction".
The HRP was a programme of the World Health Organisation (WHO) until
1988 when the World Bank, the United Nations Population Fund (UNFPA)
and the United Nations Development Programme (UNDP) joined WHO as
co-sponsors. WHO retains the predominant position of Executing Agency.
The HRP has published annual reports, the last of which was the Annual
Report 1985. The H RP now publishes reports every two years. The first of these
- the Biennial Report 1986-1987 - was published in 1988. The Biennial
Report 1988-1989 should be available mid-1990 .
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Interview
(Q) Senator, you have been publicly critical in recent years of the
involvement of the Human Reproduction Programme (HRP) in devising
new abortion technology. Can you explain your concerns?

(A) I am concerned about the lack of proper ethical evaluation and
public scrutiny of the HRP programme, and about the population control
mentality which seems to be a prime motivation of many of those involved.
I can elaborate on these issues later if you wish.
Specifically, the solid backing the HRP has given , and continues to give,
to the development, the testing and the trialing of new abortion technology
is a most disturbing - and most destructive - aspect of the HRP.
(Q)

What new abortion technology are your referring to?

(A) The abortion drug RU 486, and the abortion-producing anti-hCG
vaccine.
The HRP has had a long involvement in the development of new
abortion drugs. Until 1985, the HRP had a special Task Force - the Task
Force on Prostaglandins for Fertility Regulation - the aims of which,
according to the HRP Annual Report 1985 were:
I. The development of a non-surgical method for which the termination of
earl y first trimester pregnancy which could , in suitable circumstances, be selfadministered or supervised on an outpatient basis;
2. The development of a non-surgical , non-invasive method for the
termination of second trimester pregnancy."2

This anti-life research has been going on for nearly 20 years. It's because
of the furore over R U 486 that ordinary people are beginning to realise
that, in this area, WHO has a great deal to answer for.
(Q) You mentioned RU 486. The HRP AnnuaiReportl985 said that an
HRP Task Force - the newly-formed Task Force on Post-Ovulatory
Methods - had "made research on these compounds its top priority."3
The Report then says that the HRP wants to make RU 486 available as
soon as possible so that "the public may benefit from this breakthrough in
fertility regulation."4 Do you sense a delirious excitement within the HRP
over this new abortion technology?

(A) The HRP is not taking credit for originally developing the abortion
drug RU 486. This is not the work of Dr. Baulieu of France, and the
Roussel-UCLAF drug company. What the HRP is openly proud of is its
work in making R U 486 more "effective", and specifically, in showing that
R U 486 will be more effective in aborting the unborn if it is used in
combination with a prostaglandin.s
A number of scientists, the drug company with a vested interest, and
population controllers have made statements tinged with delirium about
R U 486. The HRP Task Force involved indicated in 1988 that their main
emphasis will continue to be on clinical trials to establish what mix of
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R U 486 and prostaglandin will most "effectively" destroy the unborn 6 , and
on testing of the so-called "NIH antiprogestins", abortion drugs
synthesised by a USA institute under contract from the National Institutes
of Health. 6a
Q. The WHO "Statement on RU 486" says that "although abortion is
not acceptable as a family planning method (WHO emphasis) the
Programme recognises that safe and effective medical methods of early
termination of pregnancy have the potential for less adverse side effects
(psychological, physical and medical) than surgical methods."7 Do you
accept this argument?
A. This is not a "value-free" argument. There is no mention of the
unborn child. WHO is indicating that it is not concerned about the health
of the tiny victim of abortion.
WHO's assertion of "less adverse side effects" - the correct term is "ill
effects" is curious. Apart from the doubtful character of such conjecture,
under what article of its charter does WHO involve itself with developing
and testing a drug which does not cure or manage a disease but, rather,
results in death for the unborn and ill effects for the mother?
Q. WHO justifies this by arguing that, after all, abortion is legal in many
countries, and that the health and medical implications of unsafe abortion
in less developed countries, are such that WHO, under its mandate, must
intervene. Do you accept this?
Abortion Lobby
A. Let me use this analogy. WHO is actively involved in the current
debate over the health implications of cigarette smoking. But is WHO
encouraging the use of filters? Is it encouraging the use of cigarettes with
lower nicotine or tar content? On the contrary, it is actively discouraging
people from smoking. It is saying: smoking is bad, smoking is wrong. You
must quiP
Yet, when it comes to something which has as many ethical implications
as abortion, what does WHO do? It adopts the position of the abortion
lobby: abortion is here to stay, so we must make it "safer" and more
"effective".
Frankly, it is disturbing to find WHO putting forward the same
arguments in defence of abortion as are being put forward by many
anti-life activists in our current national abortion debates .
Q. Do you think pro-abortion elements have conspired to shape the
HRP agenda?
A. I prefer not to refer to it as a conspiracy. However, I do believe that
the HRP has provided a unique forum where pro-abortion interests and
the technological imperative have coincided.
For instance, priorities and policies within the HRP are effectively set
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by a small group of scientists who form the Scientific and Technical
Advisory Group (STAG) . Yet, how many people know that Dr. E.
Baulieu, the so-called "father of RU 486," was appointed to this group in
1985? Furthermore, Baulieu co-edited a book in 1985 on R U 486 with the
Rockefeller Foundation's Dr. Sheldon Segal who , it turns out , also
because a member of STAG in 1985 .
(Q) Have WHO managers tried to limit the pro-abortion influence on
the direction of the HRP?
(A) With an organisation as large and as complex as WHO it is difficult
to establish how decisions were made and priorities determined. The
evidence now emerging, however, points to the strong support that WHO
managers gave to these elements of the HRP programme.
Just in the last year we have had two ex-WHO bureaucrats both putting
their weight behind the abortion drug R U 486.
First, there was Halfdan Mahler, Director of WHO until 1988, and now
the head of the International Planned Parenthood Federation - an
organisation which the United States no longer funds because it supports
abortion . He was recently reported to have accused opponents of R U 486
of adopting a "fanatic ideological posture".9
Then we had the Director of the HRP until 1989, Jose Barzelatto, now a
senior advisor to the Ford Foundation, who was recently quoted as saying
that RU 486 "must be made availablefor humanitarian reasons", calling it
a "glaring injustice that the most deprived women cannot share in the
medical advances enjoyed by their sisters in France."lo

(Q) Dr. Nafis Sadik - who is now head of one of the HRP co-sponsors,
the United Nations Population Fund, UNFP A - told a fertility
symposium in 1983 that:
" ... I would say that a menses inducer which was self-administered could really
change the course of family planning programmes ... a woman could then be
free to take something, not after coitus or at other times , but only when she
thought she was pregnant .. . If I had the choice and the authority, I would put
the major research investment in this one area.""

Do you think R U 486 has come as a "magic bullet" to the population
control movement?
(A) With this attitude, and coming from someone who now has much
"authority" as head of UNFPA, abortion drugs like RU 486 and the
anti-heG abortifacient vaccine will clearly slot easily into existing
popUlation control delivery systems. The ultimate objective of the
popUlation control movement is control over women's bodies , making
them slaves to drugs and anti-life devices . Australia's current representative on STAG, Professor R. V. Short, said as far back as 1969 that "if we
are to control human populations , one of the things we need to control is
the human corpus luteum."12 That is what these new abortion drugs will
do .
.
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When the HRP attempts to justify this work by claiming that more
efficient abortion technology is needed for health reasons, are you saying
that it is not telling the whole truth?

(Q)

(A) There are two ways of assessing this. The first is to look at what the
HRP has said about the abortion drug R U 486, and the second is to look at
how others view it.
A study of HRP documents reveals that RU 486 is not just about
making the killing of the unborn " safer" in developing countries. The
agenda is much wider. For instance , the HRP Annual Report 1985 talks
about it constituting "a more pragmatic approach by offering fertility
regulation if and when needed."13
In other words , the HRP itself sees RU 486 as a major new approach ,
not only to abortion, but to birth control.
Outside the HRP, RU 486 is being hailed , not because it is an advance in
so-called "reproductive health", but because, as a prominent birth control
advocate , Carl Djerassi , said in July last year, it will be "the most
significant research achievement of the 1990's in new practical fertility
control."14

The other weapon in what you have termed chemical warfare against
the unborn is the anti-hCG vaccine. What stage is this vaccine at?

(Q)

(A) For a number of years, the HRP has been working on the
development of a vaccine that would have the effect of making the
mother's body reject the embryo that has implanted , or is in the process of
implanting, in her womb . The human embryo produces a hormone called
hCG, or human Chorionic Gonadotrophin. This hormone is essential for
implantation and the maintenance of pregnancy. The effect of the vaccine
would be to effectively neutralise this hormone, and the human embryo
would die.
Phase I trials have been conducted in Adelaide , Australia, by Professor
Warren Jones, under the supervision of the drug company which owns the
patent, Sandoz, and on behalf of the HRP. Work is also being done by a
number of scientists in the US, and by organisations like the New Yorkbased Population Council. A marketable vaccine is still a few years down
the track. I believe that the H RP is aiming for a vaccine that will be
effective for two to five years.

When you spoke at the "New Era for Life" conference in Manila in
June 1988 you asked the question: "Has 'good medicine' and world health
policy come to this: that for the first time in human history our newest
members of the human race are to be regarded as a disease for which a
vaccine must be found?" Is it fair to think of this particular vaccine in such
terms?15

(Q)

(A) I actually borrowed the analogy from the HRP itself. In the Annual
Report 1984, for example , the HRP argues that the widespread
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"acceptance" of a birth control vaccine is assured because of the "success
achieved by immunization programmes in controlling infectious
diseases. "16
The HRP continually refers to how this vaccine will "revolutionise"
family planning in developing countries - it talks about how such a
vaccine would be an "attractive addition to the present family planning
armamentarium" - and will be readily "accepted" because people in these
countries are already familiar with vaccination procedures. 17
This worries me greatly. Can you imagine what power over women such
a vaccine is going to give the population controllers in places like China,
Bangladesh, or Indonesia? As the depo-provera saga has shown, injectable
population control drugs in an era of population control mania are
inherently dangerous .
The anti-hCG vaccine is bad news. If the HRP scientists and
technologists get their way, the first casualty will be the unborn. The
second casualty will be the truth . The anti-hCG vaccine is an abortionproducing vaccine. It is not a contraceptive vaccine as some scientists have
tried to label it. They are not telling the public the truth . Given the past
record of population control programmes, it is highly unlikely that women
in the developing countries will be told the truth as to how the vaccine
works either.
(Q) Earlier you agreed that some scientists and others appeared
somewhat delirious at what they considered to be this new "pragmatic
approach to feritIity regulation", ie RU 486. A recent issue of the journal
Science, claimed that anti-fertiliy vaccines "would radically change our
perception of human fertility if teenage males or females or both were
vaccinated so that they would be infertile until a conscious step was taken
to achieve fertility."1 8
Does this conflict with the official HRP line that "abortion is not
acceptable as a means of family planning"?

(A) It certainly indicates that the H RP has a wider agenda than it
normally admits. I believe the official line on abortion is designed to
assuage pro-life concerns. But it is hollow rhetoric. On the one hand , the
HRP says it does not accept abortion for fertility regulation purposes. Yet
on the other hand, it is rushing to develop new abortion technology which,
like the anti-hCG vaccine, will become part of the family planning
"armamentarium", or which , like th R U 486 abortion drug, will be , to
quote the HRP, a "more pragmatic approach by offering fertility
regulation if and when needed", and "essential to remedy the consequences
of contraceptive failure". 19
The HRP can't have it both ways. It can't say, as it did in its Annual
Report 1983, that its objective is "to develop for family planning
programmes entirely new birth control modalities which they consider
would considerably extend acceptance and use, eg ... abortifacient drugs ,
vaccines . . . "20, and then turn around and say that "abortion is not
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acceptable as a means of family planning."
Norcan the HRP wash its hands of the uses to which others are claiming
the new abortion technology will - and, they would urge, should - be
put. The scientists clearly think these new abortifacients are the family
planning techniques of the future. The HRP should stop trying to delude
the public, and itself, into believing otherwise.
Many people would be quite shocked to hear all this. How is it that
an organisation are reputable as the World Health Organisation could
become so deeply involved in research that, from a pro-life perspective, is
of sudl great concern?

(Q)

(A) My belief is that the answer lies in two aspects of the Human
Reproduction Programme: its ethos, and its ethics.
The HRP was born at a time when the population "bomb" theory was
fashionable, and mostly well-meaning governments the world over were
looking for solutions as to how this "bomb" might be defused .
Wasn't it the hysteria and doomsday pessimism that needed
defusing?

(Q)

(A) That's true, but the mood at the time, influenced by such pessimists
as Paul Ehrlich - who is currently going through a recycling phase
-precluded rational and calm debate. In this climate, WHO launched the
HRP and gave it a mandate to improve existing methods and develop new
techniques that could be used primarily to stem population growth in the
developing countries.
(Q) The extent ofthe population control rhetoric in theB;enn;alReport
1986-1987 is quite surprising. One of the senior HRP officials, Dr

Mahmoud Fathalla, wrote in that report that "the unregulated quantity of
human reproduction has thus become a major global concern with the
balance between man and nature in serious jeopardy and the entire future
of mankind at stake."21 Coming from a man who has just taken over as the
new Director of the HRP, this attitude - this climbing aboard the
eco-doom bandwagon - must be of some concern to you?
(A) I believe that the Annual Report 1986-1987 indicated a marked
deterioration of the HRP attitude to popUlation control. This overt linking
of the HRP agenda with the doomsday scenario is cause for great concern.
(Q)

Why do you think the HRP has openly embraced this mentality?

(A) I believe that this is due to a large extent to the recent co-sponsorship
of the HRP by organisations such as the United Nations Population Fund
(UNFPA), and the cosy relationship the HRP has with pressure groups
like the International Planned Parenthood Federation and the Population
Council.
All of these groups have sought to re-justify their existence in terms that
sound deceptively sweet to an environmentally-conscious world.
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Other elements combine with this population control mentality to form
the HRP ethos. I mentioned earlier the "technological imperative". The
idea that what can be done should and shall be done is very strong within
the HRP, influenced largely by the dominance of scientists and
technologists in the Programme. They feel they are at the cutting edge , the
technological coal-face in birth control research, and nothing will stop
them, or, as Dr. Barzelatto, the former HRP Director, said recently of
abortion drugs like RU 486, "they're too important to be stopped."22
When you put these two elements together, what emerges is a mind-set
that urges these HRP scientists on to develop ever more efficient
technology - including abortion technology - which they then turn over
to the population controllers. This is part of the HRP ethos.
(Q)

What about ethical considerations?

(A) I first raised the issue of the ethical evaluations undertaken by the
HRP in the Australian Parliament in October 1988. Let me read from the
Hansard the question I asked:
.. I ask whether prior to the decision by that Committee [of the H RP] to trial.
test , and possibly use the abortifacient anti-hCG vaccine and the drug R U 486 for
termination of pregnancy. was there any ethical evaluation at international level
prior to the request made to the Department [DCSH , Australia] regarding their
trial in Australia? If there was , who undertook such evaluationsT23

The response I received from the Department of Community Services
and Health was that it was "not aware of any ethical evaluation at the
international level prior to the decision by WHO to trial and possibly use
the abortifacient anti-hCG vaccine or the abortion drug RU 486."24
(Q)

But, you did receive a less straightforward reponse from the HRP?

(A) An official at the Australian Embassy in London did consult Dr
Barzelatto , the Director of the H R P at that time . I have here a copy of the
response provided by Dr Barzaletto. He claims that the abortifacient
anti-hCG vaccine and the abortion drug RU 486 "underwent ethical
evaluation at the international level during the exhaustive process of
sequential review . .. " . But when you scrape the rhetoric away it is scientists
reviewing scientists.
As I indicated earlier, the real power within the H R P lies with the small
Scientific and Technical Advisory Group, members of which include such
people as Dr Baulieu. In practice, the HRP takes the view that the research
is too important to stop. If one country won't allow trials to take place, it
will find another country that will.
(Q) The resurgence in pro-life concerns, particularly in the United
States, has led to the HRP coming under fire from many directions. Is the
HRP likely to reassess its priorities?

(A) I think we need to examine the defence mechanisms that large and
centralised international organisations , like WHO, display when
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contronted by criticism.
We have already seen WHO shift responsibility for the HRP to three
other international organisations, while retaining a very large finger in the
pie. This is going to make it much harder to scrutinise HRP activities.
These organisations will all rally to defend the H RP when anyone
challenges this so-called "emerging international consensus" on issues
concerning human reproduction.
Also, we are witnessing a major effort by the H RP to export its ethos to
developing countries. According to the Annual Report 1986-1987. of a
total budget for the 1986/ 87 biennium of US$22. 7 million, approximately
US$13 million went to "strengthening" institutions in developing countries
and for training scientists from such countries. This is a very long and
lavish gravy train . Having scientists in developing countries cloned in the
image and values of some anti-life scientists in the West will undoubtedly
pose grave problems for humankind .
(Q)

WHO traditionally has a good image. Is this a stumbling block?

(A) The first hurdle that a person or organisation concerned about the
nature of HRP research must clear is the good name and reputation that
WHO has within the community. I believe that WHO is conscious that this
image enables it to pursue research which, if carried out by other, more
tangible or controversial organisations, could attract criticism.
In an article written in April 1989, Dr Barzaletto noted that "the
work of WHO in the field of human reproduction covers an extremely
sensitive and controversial field . . .", and he mentions specifically,
"research directed to the medical termination of pregnancy."25
(Q)

(A) The point about that is not that WHO or the HRP is in any way
apologetic about this involvement in abortion research. The former
Director-General of WHO, Halfdan Mahler, now with IPPF, said way
back in 1983 that WHO's perceived neutrality made it "a most appropriate
instrument to deal with an area as sensitive as that of family planning
research ."26 In other words, it believed it could avoid the abortion debate,
and the political scrutiny and community concern that such anti-life
research should involve.
In a 1987 article, it was stated that "fewer and fewer pharmaceutical
companies are undertaking research on new methods offertility regulation
... hence ... a greater burden is placed on the public sector agencies - such
as WHO's Special Programme of Research in Human Reproduction ... "27
Are you concerned at this trend?

(Q)

(A) It is true that the public sector is moving in where some drug
companies - particularly in the United States - are moving out.
It is also true that the strong stand the United States has taken against
abortion has influenced the decision of a number of international
organisations to take the lead in this area . The Australian Government's
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advisor on HRP matters actually wrote in November 1984 that "the recent
strong stand of the USA at the International Conference on Population
against abortion and funding for organisations which encourage or
promote abortion in their programs makes it unlikely that the USA will
become a donor to the HRP."28 In 1985 she added that "because of the
USA attitude on abortion, WHO is the only agency which can support
research in this area."28
This indicates that the strong US position against abortion has had a
wide-ranging and positive impact. Nevertheless, the implications of this
trend towards greater public sector involvement are such that pressure
must be brought to bear on these international organisations to abandon
their support for abortion , and abortion drugs .
(Q) No doubt there are ways in which ordinary citizens can influence the
debate. Do you think that the recent "greening" of the World Bank
indicates that big bureaucracies can and do respond to the concerns of
ordinary people?

(A) The "greening" of the World Bank should serve as a reminder that
bureaucratic or utilitarian scientist-controlled organisations can and do
change, but are unlikely to change on their own initiative.
First, we need to tackle the technological imperative mentality. The
HRP must not be allowed to hide behind the "we are only here to serve the
international community by developing more efficient abortion technology" smokescreen. All actions have consequences, and ethics must not
be sacrificed in the rush to develop more potent chemical weapons against
the unborn .
Second, we must point out the dangerous linking of the HRP to
population control mania. Cases like the inherently coercive population
control programme in China, which the HRP is actively supporting,
illustrates the point that new technology produced by the HRP cannot be
divorced from the use to which it will be put. This point was not lost on the
judges at Nuremburg.
Third, the HRP must be challenged on the assertion that it is developing
more advanced abortion technology because "after all , abortion is legal in
many countries." Once these abortion drugs are ready for use , we can be
sure that the World Bank, IPPF, WHO, and UNFPA will press for their
use everywhere. Not to mention the impact of international drug
companies with vested interests, and those groups with other agendas
which say that this abortion technology, once developed, is the "moral
property" of women everywhere.
(Q)

What about the question of funding the HRP?

(A) Most governments provide money to WHO. WHO, in turn , gave the
HRP US$816,OOO in 1987. Many governments fund the World Bank. In
1987, the World Bank gave the HRP US$I million. UNFPAgave it US$3
million, the UK gave US$3 .83 million, and the combined Sweden /
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Denmark/ Norway grant was US$7 . i million.
(Q)

How actively has Australia supported the HRP?

(A) Australia first began contributing to the HRP in 1980, and has
provided about US$1.2 million since, the last grant being A$250,000 in
1989/ 90. This money comes from the foreign aid budget of the Australian
International Development Assistance Bureau (AIDAB).
AIDAB has not widely broadcast its involvement in the HRP . It is
apparent that population control remains an important element of our
involvement. In a briefing note for the Australian representative at the
annual meeting of the H RP governing body in 1982, the representative was
told not to support moves that could end up "putting the whole goal of
population control injeopardy."29 An AIDAB booklet published in 1988
referred to the Australian grant to the HRP as supporting "research on
population control".30 Only recently, and under pressure, has AIDAB
started to tone down this line.
(Q) The Australian Minister for Foreign Affairs and Trade, Senator
Gareth Evans, said in March 1989 that "the humanitarian and maternal
health implications of developing safer, non-invasive technology for
pregnancy termination are much clearer than the ethical and religious
aspects."31 Does this satisfy your concerns?

(A) It actually confirms the fears I have expressed all along. Technology
should not be put before ethics. The development of new methods of
killing the unborn can hardly be described as a "humanitarian" way of
spending our foreign aid dollars .
The Minister's comments show an abysmal ignorance of the widespread
human rights violations perpetrated by popUlation controllers who, in the
1990's, expect to receive the HRP abortion technologies into their
"armamentarium" .
(Q) You campaigned in 1988 to have trials of the abortion drug RU 486
stopped in Australia, and Roussel ended up withdrawing their clinical trial
application. Despite the influence ofthe abortion lobby on the direction of
the HRP, are you confident that those who support pro-life values can
influence the future direction of the programme?
(A) In that 1982 briefing note , the representative of the Australian
Government on the HRP was informed that "HRP attracts public
criticism in Australia" but that "such criticism evaporates when the facts
are stated and understood (eg on abortion . . .)".32
That was in 1982. When we look at the facts in 1990 and see that the right
to life of the unborn child is being treated with greater contempt, and see
that women in the developing countries are still being treated as pawns in
the deadly game of popUlation control, the criticisms are not going to
"evaporate".
(Q)
78
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I will continue to vigorously pursue these issues of major public
policy, and I am confident that concerned people, both in the pro-life
movement and in the wider community, will use whatever opportunities
they have to project these issues and demand action.
I believe that the influence of the population control lobby on the HRP
will become more evident. However, as one of those genuinely concerned
about the environment, I refuse to accept the view being promoted by
population control bureaucrats whose fatal diagnosis is that people
growth in developing countries is the cause of global environmental
problems and population control the solution. This diagnosis is deceptive,
simplistic, and directs attention away from the real problems.
It is our disposable, throw-away society which is polluting its own
environment. This same mentality is now poisoning society's respect for
human life - the very respect which is fundamental to all human rights .
This week I am attending an Inter-Parliamentary Conference on the
Global Environment convened by the US Senate. As in the past, a number
of international organisations will be lobbying for greater resources to be
spent on population control and human reproduction research . In a
subsequent interview, I will deal with issues raised by the resurgence of this
population control mentality.
(A)
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